BCW Index Posts Modest Gain Led By Bruker | GenomeWeb

Shares in Bruker Biosciences rose 5.8 percent for the trading week ended Tuesday to lead the BCW Index to a modest gain. The firm did not report any news and trading volume was slightly lower than average for the week. Stratagene led decliners with a 4.5-percent drop for the tracking period. The firm announced last week that it had posted a $21-million bond to secure damages in its legal dispute with Third Wave Technologies (see Briefs).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.